Related Experiment Video
Updated: Nov 21, 2025

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
Published on: October 31, 2025
Statin-induced necrotizing autoimmune myopathy.
Syed A Huda1, Sanjay Yadava1, Sara Kahlown2
1Department of Internal Medicine, State University of New York Upstate Medical University, Syracuse, New York.
Statins can cause a rare autoimmune muscle disease called statin-induced necrotizing autoimmune myopathy (SINAM). Intravenous immunoglobulin effectively treated a patient with this condition.
Area of Science:
- Pharmacology
- Immunology
- Neurology
Background:
- Statins are widely prescribed cholesterol-lowering drugs.
- 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibition is their primary mechanism.
- Common side effects include myalgias and elevated liver enzymes.
Observation:
- Statin-induced necrotizing autoimmune myopathy (SINAM) is a rare adverse effect.
- SINAM is independent of statin type and duration.
- It presents as severe muscle weakness and elevated creatine kinase.
Findings:
- Treatment typically involves high-dose steroids and immunosuppressants (azathioprine, methotrexate, mycophenolate mofetil).
- Intravenous immunoglobulin (IVIg) or rituximab are options for non-responders or severe cases.
- This case highlights successful SINAM treatment with IVIg.
Implications:
- Understanding rare statin side effects is crucial for patient safety.
- Immunomodulatory therapies like IVIg offer treatment options for refractory SINAM.
- Further research into the pathogenesis and management of SINAM is warranted.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Myocarditis I: Introduction
Myocarditis III: Medical Management
Satellite Stem Cells and Muscular Dystrophy

